ISRG vs. DXCM, GOOG, HSIC, IDXX, ELV, EW, ITGR, JNJ, MDT, and SYK
Should you be buying Intuitive Surgical stock or one of its competitors? The main competitors of Intuitive Surgical include DexCom (DXCM), Alphabet (GOOG), Henry Schein (HSIC), IDEXX Laboratories (IDXX), Elevance Health (ELV), Edwards Lifesciences (EW), Integer (ITGR), Johnson & Johnson (JNJ), Medtronic (MDT), and Stryker (SYK).
Intuitive Surgical vs. Its Competitors
Intuitive Surgical (NASDAQ:ISRG) and DexCom (NASDAQ:DXCM) are both large-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, earnings, media sentiment, valuation, dividends, profitability, risk and analyst recommendations.
Intuitive Surgical has a net margin of 28.51% compared to DexCom's net margin of 13.29%. DexCom's return on equity of 30.41% beat Intuitive Surgical's return on equity.
Intuitive Surgical has a beta of 1.61, indicating that its share price is 61% more volatile than the S&P 500. Comparatively, DexCom has a beta of 1.47, indicating that its share price is 47% more volatile than the S&P 500.
83.6% of Intuitive Surgical shares are held by institutional investors. Comparatively, 97.8% of DexCom shares are held by institutional investors. 0.7% of Intuitive Surgical shares are held by company insiders. Comparatively, 0.3% of DexCom shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
In the previous week, Intuitive Surgical had 45 more articles in the media than DexCom. MarketBeat recorded 67 mentions for Intuitive Surgical and 22 mentions for DexCom. Intuitive Surgical's average media sentiment score of 1.09 beat DexCom's score of 0.72 indicating that Intuitive Surgical is being referred to more favorably in the media.
Intuitive Surgical has higher revenue and earnings than DexCom. DexCom is trading at a lower price-to-earnings ratio than Intuitive Surgical, indicating that it is currently the more affordable of the two stocks.
Intuitive Surgical currently has a consensus target price of $594.19, suggesting a potential upside of 32.13%. DexCom has a consensus target price of $98.32, suggesting a potential upside of 48.16%. Given DexCom's stronger consensus rating and higher probable upside, analysts plainly believe DexCom is more favorable than Intuitive Surgical.
Summary
Intuitive Surgical beats DexCom on 11 of the 16 factors compared between the two stocks.
Get Intuitive Surgical News Delivered to You Automatically
Sign up to receive the latest news and ratings for ISRG and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding ISRG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Intuitive Surgical Competitors List
Related Companies and Tools
This page (NASDAQ:ISRG) was last updated on 10/6/2025 by MarketBeat.com Staff